Avalo Therapeutics (C6K0) Revenue

0 Followers

Avalo Therapeutics Revenue

Avalo Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with ―. This bring the company's revenue in the last twelve months to 59.00K, Decreased 0.00%. In the fiscal year ending Dec 31, 2025, Avalo Therapeutics had annual revenue of 59.00K with -86.62% growth.

Revenue (ttm)

59.00K

Revenue Growth

-87.53%

P/S Ratio

12646.25

Revenue/Employee

€1,788

Employees

Market Cap

€746.13M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	59.00K	-382.00K	-86.62%
Dec 31, 2024	441.00K	-1.48M	-77.08%
Dec 31, 2023	1.92M	-16.13M	-89.34%
Dec 31, 2022	18.05M	12.65M	+234.40%
Dec 31, 2021	5.40M	-1.30M	-19.42%
Dec 31, 2020	6.70M	-51.35K	-0.76%
Dec 31, 2019	6.75M	-11.58M	-63.17%
Dec 31, 2018	18.33M	-9.49M	-34.11%
Dec 31, 2017	27.81M	―	―